{
    "clinical_study": {
        "@rank": "144463", 
        "arm_group": {
            "arm_group_label": "Diffusion weighted imaging, Recurrence", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Endometrial and cervical cancers are one of the most common malignancies seen in females.\n      Identification of recurrent disease in early phases of treatment carries a primary\n      importance on the outcome of patients. Diffusion-weighted magnetic resonance imaging (DWI)\n      is a new technique recently started to be performed in body imaging and has potential\n      ability to detect recurrent disease. The aim of this study is to investigate the diagnostic\n      impact of DWI in detection of recurrent disease in patients treated with curative surgery in\n      endometrial and cervical cancer."
        }, 
        "brief_title": "Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cervical Cancer", 
            "Endometrial Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Body Weight", 
                "Endometrial Neoplasms", 
                "Sarcoma, Endometrial Stromal", 
                "Uterine Cervical Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Endometrial and cervical cancers are one of the most common malignancies seen in female\n      genital tract. Although, surgical resection is the treatment of choice for both, adjuvant or\n      neo-adjuvant chemotherapy or radiotherapy and curative radiotherapy are alternative\n      treatment options depending on the stage.\n\n      Identification of recurrent disease in early phases carries a primary importance  on the\n      prognosis.\n\n      Diffusion-weighted MRI (DWI), a new technique recently started to be performed in body\n      imaging has potential ability to distinguish recurrent disease from normal tissue or\n      fibrosis. Our aim in this study is to investigate the diagnostic impact of DWI in detection\n      of recurrence rate in patients treated with curative surgery in endometrial and cervical\n      cancer.\n\n      All patients who had curative surgery due to endometrial or cervical cancer will be included\n      to the study. Patients will be examined with DWI in addition to routine sequences including\n      contrast enhanced dynamic studies. The sensitivity, specificity, accuracy as well as\n      positive and negative predictive values of the study will be investigated from the data\n      derived from DWI studies and will be correlated with data obtained by conventional\n      radiologic, nuclear imaging studies including PET-CT, as well as pathologic verifications\n      during follow-up period."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pathologic diagnosis of cervical or endometrial cancer.\n\n          -  Patients treated with curative surgery (hysterectomy)will be involved on a voluntary\n             basis.\n\n        Exclusion Criteria:\n\n          -  Contraindications for MRI examination (cardiac pacemakers, metallic objects, cochlear\n             implants, claustrophobic patients)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01710085", 
            "org_study_id": "KUAP(T)-2012/39"
        }, 
        "intervention": {
            "arm_group_label": "Diffusion weighted imaging, Recurrence", 
            "description": "Recurrence in cervical and endometrial cancer patients who were treated with curative surgery is routinely investigated by MRI examination. MRI is diagnostic technique not requiring ionizing radiation and is based on magnetic fields.", 
            "intervention_name": "Diffusion weighted MRI (DW- MRI)- Philips Achieva 3.0T X, Netherlands, 2011", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Diffusion weighted MRI", 
            "Curative surgery", 
            "Recurrence"
        ], 
        "lastchanged_date": "October 16, 2012", 
        "location": {
            "contact": {
                "email": "hacikurt@uludag.edu.tr", 
                "last_name": "Kadir Hac\u0131kurt", 
                "phone": "+905055873273"
            }, 
            "facility": {
                "address": {
                    "city": "Bursa", 
                    "country": "Turkey"
                }, 
                "name": "Uluda\u011f \u00dcniversitesi"
            }, 
            "investigator": [
                {
                    "last_name": "Kadir Hac\u0131kurt", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "G\u00fcrsel Savc\u0131", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "1", 
        "official_title": "Diagnostic Value of Diffusion Weighted Imaging in Detection of Recurrent Disease in Cervical and Endometrial Cancer Treated With Curative Surgery", 
        "overall_contact": {
            "email": "hacikurt@uludag.edu.tr", 
            "last_name": "Kadir Hac\u0131kurt", 
            "phone": "+905055873273"
        }, 
        "overall_contact_backup": {
            "email": "gsavci@uludag.edu.tr", 
            "last_name": "G\u00fcrsel Savc\u0131"
        }, 
        "overall_official": [
            {
                "affiliation": "Uludag University Faculty of Medicine", 
                "last_name": "G\u00fcrsel Savc\u0131, Prof.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Uludag University Faculty of Medicine", 
                "last_name": "Kadir Hac\u0131kurt, Dr.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Postoperative recurrent disease is usually investigated with physical examination, ultrasonography, computed tomography (CT), conventional magnetic resonance imaging (MRI) and positron emission tomography-computed tomography (PET-CT) with different sensitivity and specificities. However, radiologists experience difficulty in detection of small recurrent active tumors with anatomically-based radiologic modalities like CT or conventional MRI in patients treated with hysterectomy.  Furthermore, effects of adjuvant therapies or fibrosis developed following surgery could mask or even mimic the recurrent tumor. Our aim in this study is to investigate the diagnostic impact of DWI in detection of recurrence rate in patients treated with curative surgery in endometrial and cervical cancer.", 
            "measure": "Investigation of the diagnostic value of DWI in detection of recurrence rate in patients treated with curative surgery in endometrial and cervical cancer.", 
            "safety_issue": "No", 
            "time_frame": "18 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01710085"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Uludag University", 
            "investigator_full_name": "Kadir Hacikurt", 
            "investigator_title": "Dr. Kadir Hac\u0131kurt", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Uludag University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Uludag University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}